Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany; Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, 88397 Biberach an der Riß, Germany.
Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
Cell Rep Med. 2023 Jul 18;4(7):101125. doi: 10.1016/j.xcrm.2023.101125.
Acute graft-versus-host disease (aGvHD) is a significant complication after allogeneic hematopoietic stem cell transplantation (aHSCT), but major factors determining disease severity are not well defined yet. By combining multiplexed tissue imaging and single-cell RNA sequencing on gastrointestinal biopsies from aHSCT-treated individuals with fecal microbiome analysis, we link high microbiome diversity and the abundance of short-chain fatty acid-producing bacteria to the sustenance of suppressive regulatory T cells (Tregs). Furthermore, aGvHD severity strongly associates with the clonal expansion of mainly CD8 T cells, which we find distributed over anatomically distant regions of the gut, persistent over time, and inversely correlated with the presence of suppressive Tregs. Overall, our study highlights the pathophysiological importance of expanded CD8 T cell clones in the progression of aGvHD toward more severe clinical manifestations and strongly supports the further development of microbiome interventions as GvHD treatment via repopulation of the gut Treg niche to suppress inflammation.
急性移植物抗宿主病(aGvHD)是异基因造血干细胞移植(aHSCT)后的一个严重并发症,但严重程度的主要决定因素尚未明确。通过对接受 aHSCT 治疗的个体的胃肠道活检进行多重组织成像和单细胞 RNA 测序,并结合粪便微生物组分析,我们将高微生物多样性和产生短链脂肪酸的细菌丰度与抑制性调节性 T 细胞(Tregs)的维持联系起来。此外,aGvHD 的严重程度与主要为 CD8 T 细胞的克隆扩增强烈相关,我们发现这些 CD8 T 细胞分布在肠道的解剖学上遥远的区域,随着时间的推移持续存在,并与抑制性 Tregs 的存在呈负相关。总的来说,我们的研究强调了扩展的 CD8 T 细胞克隆在 aGvHD 向更严重临床表现进展中的病理生理重要性,并强烈支持通过重新填充肠道 Treg 龛位来抑制炎症,进一步开发微生物组干预作为 GvHD 治疗的方法。